Complications from HIV / AIDS
Pulmonary complications are exceedingly common among patients infected with HIV. Moreover, the longer life expectancy of HIV-infected individuals has led to the recognition of many infectious and non-infectious pulmonary complications, including the well-established association between HIV and pulmonary hypertension (HIV-PH). The practice is the referral group for all HIV providers within Boston Medical Center for evaluation and treatment of the pulmonary and mycobacterial complications that occur in HIV-infected individuals.
The Interventional Bronchoscopy program is dedicated to the care of patients with complex airway disease including obstructing cancers, broncholiths, relapsing polychondritis, tracheoesophageal fistulae, tracheobronchial and laryngeal amyloidosis, papillomatosis, tracheal stenoses, and tracheomalacia.
The Primary Immunodeficiency Clinic diagnoses and cares for patients with immunological conditions for which the cause is unknown. This includes patients with frequent infections and inflammatory and autoimmune diseases that do not respond to treatment. Boston Medical Center immunologists provide cutting-edge autoimmune testing and treatment, including immunoglobulin replacement therapy, precision immunomodulatory infusions, and prophylactic anti-infective agents. Patients with primary immunodeficiency also have the opportunity to participate in clinical trials funded by the National Institutes of Health, Immune Deficiency Foundation, and other organizations.
Pulmonary and Exercise Physiology
The Pulmonary Physiology service provides comprehensive, state-of-the-art assessment of respiratory mechanics and function. The goal is to assist the clinician in the diagnosis and prognosis of all forms of pulmonary-related diseases and to assist the clinical investigator in the pursuit of understanding and defining pulmonary disease through research.
The Pulmonary Hypertension Center provides special expertise in the diagnosis and management of patients with primary and secondary forms of pulmonary hypertension (PH). The team’s specialists are dedicated to improving the quality of life for patients with pulmonary hypertension through individualized management and use of the most advanced medications, including medications that are only available through clinical trials.
Sarcoidosis and Interstitial Lung Disease
Several of the team’s physicians specialize in the diagnosis and management of sarcoidosis and interstitial lung disease. They work collaboratively with other specialists at Boston Medical Center to provide comprehensive treatment for the many manifestations of sarcoidosis, including those to the heart, skin, and central nervous system. The medical staff works closely with radiology, thoracic surgery, and pathology to provide the most accurate diagnosis of interstitial lung disease. Individual management plans are based on the most current research and the experience of the physicians. Learn more about the Sarcoidosis Center at BMC.
The Scleroderma (Systemic Sclerosis) Center is a collaboration of the Pulmonary and Rheumatology Departments. The Center is recognized as a leader in scleroderma, and provides diagnosis and treatment of patients with Systemic Sclerosis. The Center is closely linked to National Institutes of Health and industry sponsored clinical, translational, and basic research, including the Scleroderma Lung Study (SLS), a collaboration of 14 clinical scleroderma centers in the United States. The goal of the Center is to provide patients with systemic sclerosis state-of-the-art patient care and the opportunity to participate in advanced therapeutic research which both improves patient quality of life and provides for a basis for understanding the pathogenesis of the disease.
The goal of the Sleep Disorders Center is to provide comprehensive, state-of-the-art diagnostic and treatment services for the full range of sleep disorders, to provide education in the practice of sleep medicine and to conduct research in the area of sleep disorders. Learn more about the Sleep Lab.
The Tuberculosis Clinical Research Group is engaged in multi-center consortium studies, investigator-initiated local research studies, and educational efforts locally, regionally, and nationally. The group is also active within the Centers for Disease Control's Tuberculosis Trials Consortium (TBTC), enrolling patients in both latent and active TB treatment trials.